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Background: There are limited data regarding the clinical outcomes of very long stent
implantation, particularly the use of second generation everolimus eluting stents
(DES).
Methods: From the IRIS-DES Registry, we identiﬁed 406 patients who were treated
for coronary stenosis using  60 mm of overlapping drug-eluting stents. Of these, 269
and 137 patients were treated using cobalt chromium everolimus eluting stent (CoCr-
EES) and platinum chromium everolimus-eluting stents (PtCr-EES), respectively.
Major adverse cardiac events (MACE) were deﬁned using a composite measure
consisting of death, myocardial infarction (MI; periprocedural or spontaneous), or
target vessel revascularization (TVR).
Results: Per target lesion, the average stent number was 2.7  0.7 and the average
stent length was 76.3  14.8 mm. On 2-year clinical follow-up, the rate of MACE,
death, spontaneous MI, TVR, and stent thrombosis (deﬁnite or probable stent
thrombosis) were 31.8%, 4.4%, 2.0%, 7.1%, and 0.5%, respectively. Although 88
patients (21.2%) suffered from periprocedural MI, this was not independently
associated with death, spontaneous MI, or TVR (hazard ratio [HR], 1.097; 95%
conﬁdence interval [CI] 0.58–2.08, p ¼ 0.775). In addition, there were no statis-
tical differences between CoCr-EES and PtCr-EES implantation in terms of the
adjusted risks of MACE (HR, 1.223; 95% CI 0.82–1.82, p ¼ 0.321) as well as its
individual components (death; HR, 0.846; 95% CI 0.311–2.305, p ¼ 0.744, MI;
HR, 1.101; 95% CI 0.686-1.768, p ¼ 0.690, TVR; HR, 1.854; 95% CI 0.895–
3.841, p ¼ 0.097)
Conclusions: When treating diffuse coronary stenosis, multiple overlapping stent
implantation using second generation DES appear to be safe and effective. Although
periprocedural MI frequently occurred, it was not associated with an increase in long-
term adverse clinical outcomes.
TCT-238
Long Term Efﬁcacy and Safety of Ultra-long Everolimus-Eluting Stent
Implantation
Yohsuke Honda1, Ren Kawaguchi2, Yusuke Miyaishi3, Hakuken Kan4,
Hiroshi Hoshizaki5, Shigeru Oshima5, Toshiya Muramatsu6
1Saiseikai Yokohama City Eastern Hospital, Yokohama, Kanagawa-ken, 2Gunma
Prefectural Cardiovascular Center, Maebashi, Gunma, 3Gunma Prefectural
Cardiovascular Center, Maebashi, Japan, 4Gunma prefectural cardiovascular center,
Maebashi, Japan, 5Gunma Prefectural Cardiovascular Center, Maebashi, Japan,
6Saiseikai Yokohama-city Eastern Hospital, Yokohama, Japan
Background: Although the long stent implantation was known as a predictor of target
lesion revascularization (TLR) or stent thrombosis (ST), EES showed favorable results
even in complicated lesions. We aimed to investigate the impact of ultra-long
EES(UL-EES) implantation in real-world practices.
Methods: A total of 587 consecutive patients(829lesions) who underwent EES
implantation were enrolled.According to total stent length,lesions were divided
into UL-EES(>50mm,21patients,25lesions),long-EES(L-EES) (30to50mm,69pa-
tients,93lesions),short-EES(S-EES) (<30mm,497patients,711lesions).Whole life dual
antiplatelet therapy was planned for the Long-EES and UL-EES patients.TLR,deﬁnite
ST,myocardial infarction (MI),death during follow-up were compared among three
groups.
Results: Prevalence of coronary risk factors was similar among three groups.
Rate of ST-segment elevation MI (STEMI) was higher in L-EES(p¼0.03). Rate
of lesiona with chronic total occlusion(p<0.001) and in right coronaryB70 JACC Vol 64/11/Suppl B j September 13–17, 2014artery(p¼0.02) were higher in UL-EES group. Overall death, MACE, MI, TLR
and ST was observed in 39patients(6.6%), 61patients(10.3%), 5patients(0.8%),
41lesions(4.9%) and 8lesions(0.9%). In cox proportional-hazards model, stent
length>30mm, >50mm, hemodialysis, peripheral artery disease were the inde-
pendent predictor of TLR (p¼<0.001,0.02,0.03,0.001). STEMI, reference
diameter<2.5mm, stent length>30mm were the independent predictor of
ST (p¼0.002,0.04,0.003). Rate of TLR and ST was signiﬁcantly lower in S-
EES (3.9%,0.6%) than UL-EES (16%,p¼0.002,4%,p¼0.03) and L-EES
(9.7%,p¼0.005,3.2%, p¼0.007) but similar between UL-EES and L-EES
(p¼0.42,0.83). Though incidence of MACE was signiﬁcantly higher in L-EES
(19.7%) than in S-EES (16%) (p¼0.02), that was similar between in S-EES and in
UL-EES (19%) (p¼0.14). No difference was observed in incidence of death
among three groups (p¼0.94).
Conclusions: Despite of the use of EES, stent length was related to TLR. However,
ultra long EES implantation under prolonged dual antiplatelet therapy showed
acceptable TLR rate and safety proﬁle for the patient’s hard events.
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Background: In the era of drug-eluting stents, multiple overlapping stents was per-
formed more than 10% of patients with diffuse coronary artery diseases. However,
correlation between the location of overlapping site and 9 month follow-up (FU)
minimum lumen diameter (MLD) site after multiple overlapping everolimus-eluting
stents (EES) was not well evaluated.
Methods: From the prospective, multi-center study of XILLION (XIence/promus for
Long coronary LesION) registry to assess the efﬁcacy of multiple overlapping EESs in
patients with diffuse long coronary artery disease, serial quantitative coronary angi-
ography (QCA) analyses at pre-, post-procedure, and 9month FU were performed for
pre-, post-procedural MLD, and overlapping sites. MLD site at FU angiography was
independently evaluated by QCA analysis.
Results: A total of 330 patients with 348 lesions were enrolled and 9 month FU
angiography was performed for all patients. In the 52% of the lesions, the location
of pre-procedural MLD was same as that of FU MLD. On the other hand, in the 72
% of the lesions, the location of post-procedural MLD was same as that of FU
MLD. All same MLD sites (pre- ¼ post-procedure ¼ FU) were observed in 44% of
lesions. New MLD site was observed at FU in 8% of lesion. MLD site was
observed at overlapping site in 5.3% of the lesion at post-procedure and 1.4% at 9
month FU. No angiographic restenosis was observed at overlapping site. Angio-
graphic data was shown in table.
Conclusions: After multiple overlapping stenting, overlapping site was not
associated with the location of MLD at pot-procedure and 9 month FU. The
location of MLD site at pre- and post-procedure correlated with at 9month
FU.j TCT Abstracts/Coronary Lesions - Long Lesions and Diffuse Disease
